Morphotek Inc. Signs Development and Clinical Supply Agreement with CMC Biopharmaceuticals A/S for Therapeutic Antibody to Treat Melanoma
5/21/2007 1:50:36 PM
More...
|
Stallergenes, S.A. (GENP.PA) and CMC Biopharmaceuticals A/S Sign Manufacturing Agreement for Recombinant Bet v 1
5/14/2007 11:56:14 AM
More...
|
CMC Biopharmaceuticals A/S Appoints Dr. Diana Morgan As Chief Business Officer
3/15/2006 1:26:17 PM
More...
|
Arexis AB Enters Into Collaboration With CMC Biopharmaceuticals A/S For The Production Of BSSL For Clinical Trials
10/19/2005 5:12:57 PM
More...
|
CMC Biopharmaceuticals A/S Completes A € 14 Million Financing Round, Introducing New Investors
10/19/2005 5:11:55 PM
More...
|
CMC Biopharmaceuticals A/S Appoints Richard Hart As Head Of Sales & Marketing
10/19/2005 5:11:27 PM
More...
|
CMC Biopharmaceuticals A/S And Syngenta Biopharma Enter Into Umbrella Agreement
10/19/2005 5:09:25 PM
More...
|
CMC Biopharmaceuticals A/S And Resistentia AB Announce A Development And Manufacturing Agreement
10/19/2005 5:09:18 PM
More...
|
EMEA Approval Of CMC Biopharmaceuticals A/S For In-Market Manufacture
10/19/2005 5:09:09 PM
More...
|
CMC Biopharmaceuticals A/S And Ambrx, Inc. Announce Development And Manufacturing Agreement
10/19/2005 5:08:45 PM
More...
|